Home World News Pfizer CEO: A third dose of 'possibly' needed within 12 months |...

Pfizer CEO: A third dose of ‘possibly’ needed within 12 months | News about the pandemic coronavirus


Researchers currently do not know how long the vaccine provides protection against coronavirus.

The head of Pfizer said that people “likely” would need a third dose of his company’s COVID-19 injection six to 12 months after vaccination, while protecting the relative cost of the injection. higher.

CEO Albert Bourla also said annual vaccinations against the coronavirus may also be required.

Bourla told broadcaster CNBC in an interview aired on Thursday: “We need to see what the sequence will be and how often we need to do that, that remains to be seen, Bourla told broadcaster CNBC in an interview aired on Thursday.

“One likely scenario would be that there would be a need for a third dose, in about six to 12 months and after that, there would be an annual re-licensing, but all of that would need to be. confirmation, ”he said and added that variant will play an “important role”.

“It is extremely important to stop potentially vulnerable groups of the virus.”

Researchers currently do not know how long the vaccine provides protection against coronavirus.

Earlier this month, Pfizer published a study saying its injection was 91% more effective in protecting against coronavirus and more than 95% effective for severe cases of COVID-19 up to six. month after the second dose.

But the researchers say more data is needed to determine whether the protection lasts after six months.

Price increase

Bourla also defends his company’s vaccine prices, saying they are saving lives and won’t sell to poor countries for a profit.

Bourla said in an interview with several European news outlets.

“They save people’s lives, allow the economy to reopen, but we sell them for the price of a meal,” he said.

According to data released a few months ago by a member of the Belgian government, the Pfizer coronavirus vaccine is the most expensive for the European Union, along with the Moderna vaccine.

Earlier this week, Bulgarian Prime Minister Boyko Borissov explained that vaccine prices were rising due to the sale being negotiated, priced at 19.50 euros ($ 23), up from 12 euros ($ 14).

Prices are in stark contrast to the vaccine produced by the Anglo-Swedish drugmaker AstraZeneca, which pledged not to profit from its products during the pandemic and sold it to the EU for less than two euros ( 2.39 USD) per unit.

Bourla does not confirm the price of the Pfizer vaccine but admits that it sells for a higher price to developed countries such as the US or countries in the EU.

“In middle-income countries, we sell it for half the price,” he said. “In poorer countries, including in Africa, we sell it at the original price.”



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments